Spatial patterns of immune cell states are associated with poor response to neoadjuvant chemotherapy in high-grade serous ovarian cancer

被引：0
|
作者：
Niemiec, Iga
Kahelin, Essi
Liang, Zhihan
Erkan, Erdogan P.
Vaharautio, Anna
Virtanen, Anni
Farkkila, Anniina
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 05期
关键词：
D O I：
10.1158/1538-7445.OVARIAN23-B077
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B077
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer
    Crispin-Ortuzar, Mireia
    Woitek, Ramona
    Reinius, Marika A. V.
    Moore, Elizabeth
    Beer, Lucian
    Bura, Vlad
    Rundo, Leonardo
    McCague, Cathal
    Ursprung, Stephan
    Sanchez, Lorena Escudero
    Martin-Gonzalez, Paula
    Mouliere, Florent
    Chandrananda, Dineika
    Morris, James
    Goranova, Teodora
    Piskorz, Anna M.
    Singh, Naveena
    Sahdev, Anju
    Pintican, Roxana
    Zerunian, Marta
    Rosenfeld, Nitzan
    Addley, Helen
    Jimenez-Linan, Mercedes
    Markowetz, Florian
    Sala, Evis
    Brenton, James D.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [32] Predicting Neoadjuvant Chemotherapy Response and High-Grade Serous Ovarian Cancer From CT Images in Ovarian Cancer with Multitask Deep Learning: A Multicenter Study
    Yin, Rui
    Guo, Yijun
    Wang, Yanyan
    Zhang, Qian
    Dou, Zhaoxiang
    Wang, Yigeng
    Qi, Lisha
    Chen, Ying
    Zhang, Chao
    Li, Huiyang
    Jian, Xiqi
    Ma, Wenjuan
    ACADEMIC RADIOLOGY, 2023, 30 : S192 - S201
  • [33] BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Patil, Akkamahadevi
    Patil, Sharada
    Anupama, C. E.
    Rajarajan, Savitha
    Nimbalkar, Vidya P.
    Amirtham, Usha
    Champaka, G.
    Suma, M. N.
    Patil, Geetha V.
    Nargund, Ashwini
    Pallavi, V. R.
    Jacob, Linu
    Premalatha, C. S.
    Prabhu, Jyothi S.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (12) : 2875 - 2882
  • [34] Determinants of resistance and response in high-grade serous ovarian cancer
    Bowtell, David D. L.
    CLINICAL CANCER RESEARCH, 2016, 22
  • [35] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Marchocki, Zibi
    Tone, Alicia
    Virtanen, Carl
    de Borja, Richard
    Clarke, Blaise
    Brown, Theodore
    May, Taymaa
    JOURNAL OF OVARIAN RESEARCH, 2022, 15 (01)
  • [36] Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer
    McAdams, Julia
    Ebott, Jasmine
    Jansen, Corinne
    Kim, Chloe
    Maiz, Daniela
    Ou, Joyce
    Hanley, Linda C.
    De La Cruz, Payton
    James, Nicole E.
    JOURNAL OF OVARIAN RESEARCH, 2024, 17 (01)
  • [37] Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma
    Zibi Marchocki
    Alicia Tone
    Carl Virtanen
    Richard de Borja
    Blaise Clarke
    Theodore Brown
    Taymaa May
    Journal of Ovarian Research, 15
  • [38] Analyzing Spatial Point Patterns in Digital Pathology: Immune Cells in High-Grade Serous Ovarian Carcinomas
    Gonzalez, Jonatan A.
    Wrobel, Julia
    Vandekar, Simon
    Moraga, Paula
    AMERICAN STATISTICIAN, 2025,
  • [39] External validation of chemotherapy response scoring system for histopathologic assessment of tumor regression after neoadjuvant chemotherapy in high-grade serous ovarian cancer
    Lee, J. Y.
    Nam, E. J.
    Kim, S. W.
    Kim, S.
    Kim, Y. T.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 118 - 118
  • [40] Circulating serum miRNAs predict response to platinum chemotherapy in high-grade serous ovarian cancer
    Suzuki, Kazuhiro
    Yokoi, Akira
    Matsuzaki, Juntaro
    Yoshida, Kosuke
    Yamamoto, Yusuke
    Kato, Tomoyasu
    Ishikawa, Mitsuya
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    CANCER MEDICINE, 2024, 13 (22):
12345